- Neuro-All - University of Manitoba Mailing Lists

TODAY | BAW Special Lecture - Dr. Pierre Marquet
by Kae Normandeau 14 Mar '18

14 Mar '18

[cid:image001.jpg@01D158FE.B69B8D00] SPECIAL LECTURE: B R A I N A W A R E N E S S W E E K D A T E Wednesday, March 14th, 2018 12Noon *Followed by a Trainee Lunch in SR415, KIAM L O C A T I O N Theatre C, BMSB S P E A K E R D R . PIERRE MARQUET C A N A D A EXCELLENCE R E S E A R C H C H A I R NEUROPHOTONICS T O P I C Neurophotonics to Intercept the Emergence of Major Psychiatric Disorders Major psychiatric disorders (MPDs) including psychosis and mood disorders affect *4% of the population. MPDs have chronic courses since their diagnoses, solely based on clinical symptoms, are very late and thus better treatments are only palliative. The successful development of early treatment and primary prevention is largely impeded by the lack of reliable risk biomarkers or endophenotypes (B/Es). This is a critical issue since MPDs have a neurodevelopmental origin and early intervention can improve outcomes. >From a developmental standpoint, the identification of B/Es in patients with MPDs and in their offspring at genetic risk will play a pivotal role in the definition of childhood risk syndromes and their corresponding abnormal trajectories. This approach is particularly relevant given that high-risk children carry many of the indicators of brain dysfunctions that adult patients have. Within this framework, I will present how the development of new multimodal optical imaging techniques in combination with stem cell technologies, including human induced pluripotent stem cells approaches, can contribute to identifying new cellular B/Es relevant both to define childhood risk syndromes and to determine cellular processes likely to be involved in the pathogenesis of these MPDs. Kae Normandeau Administrative Manager Neuroscience Research Program SR440 KIAM Building P: 204-318-2569 E: kae.normandeau(a)umanitoba.ca<mailto:kae.normandeau@umanitoba.ca> This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies. ****************************************** [cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/> [cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>

1 0

BAW SPECIAL EVENT - In Conversation with Dr. Pierre Marquet
by Kae Normandeau 12 Mar '18

12 Mar '18

[cid:image001.jpg@01D158FE.B69B8D00] B R A I N A W A R E N E S S W E E K SPECIAL EVENT: D A T E Wednesday, March 14th, 2018 7:00pm L O C A T I O N McNally Robinson Bookstore 4000-1120 Grant Avenue IN CONVERSATION WITH DR. PIERRE MARQUET C A N A D A EXCELLENCE R E S E A R C H C H A I R NEUROPHOTONICS T O P I C Identification of a childhood risk syndrome of major psychiatric diseases: a step towards their prevention. Psychiatrist, Pierre Marquet also holds a Master of physical engineering from Ecole Polytechnique Fédérale de Lausanne, Switzerland and an M.D./Ph.D. in neurophotonics from University of Lausanne. Recognized worldwide for his pioneering work on digital holographic microscopy, he is a professor of psychiatry at Université Laval and the chairholder of the CERC in Neurophotonics. He is also the director of the International Joint Research Unit (IJRU) in neurodevelopment and child psychiatry. The goal of this IJRU is to identify new risk biomarkers and endophenotypes to define childhood risk syndromes of major psychiatric disorders including schizophrenia, bipolar disorders and major depression disorder with the help of neurophotonics tools. He is the author or co-author of more than 140 scientific publications (6500 citations, h-index 36), of many patents and is the co-founder of three technological start-up companies. Kae Normandeau Administrative Manager Neuroscience Research Program SR440 KIAM Building P: 204-318-2569 E: kae.normandeau(a)umanitoba.ca<mailto:kae.normandeau@umanitoba.ca> This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies. ****************************************** [cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/> [cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>

1 0

BAW Special Lecture - Dr. Pierre Marquet | Wednesday, March 14th
by Kae Normandeau 12 Mar '18

12 Mar '18

[cid:image001.jpg@01D158FE.B69B8D00] SPECIAL LECTURE: B R A I N A W A R E N E S S W E E K D A T E Wednesday, March 14th, 2018 12Noon *Followed by a Trainee Lunch in SR415, KIAM L O C A T I O N Theatre C, BMSB S P E A K E R D R . PIERRE MARQUET C A N A D A EXCELLENCE R E S E A R C H C H A I R NEUROPHOTONICS T O P I C Neurophotonics to Intercept the Emergence of Major Psychiatric Disorders Major psychiatric disorders (MPDs) including psychosis and mood disorders affect *4% of the population. MPDs have chronic courses since their diagnoses, solely based on clinical symptoms, are very late and thus better treatments are only palliative. The successful development of early treatment and primary prevention is largely impeded by the lack of reliable risk biomarkers or endophenotypes (B/Es). This is a critical issue since MPDs have a neurodevelopmental origin and early intervention can improve outcomes. >From a developmental standpoint, the identification of B/Es in patients with MPDs and in their offspring at genetic risk will play a pivotal role in the definition of childhood risk syndromes and their corresponding abnormal trajectories. This approach is particularly relevant given that high-risk children carry many of the indicators of brain dysfunctions that adult patients have. Within this framework, I will present how the development of new multimodal optical imaging techniques in combination with stem cell technologies, including human induced pluripotent stem cells approaches, can contribute to identifying new cellular B/Es relevant both to define childhood risk syndromes and to determine cellular processes likely to be involved in the pathogenesis of these MPDs. Kae Normandeau Administrative Manager Neuroscience Research Program SR440 KIAM Building P: 204-318-2569 E: kae.normandeau(a)umanitoba.ca<mailto:kae.normandeau@umanitoba.ca> This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies. ****************************************** [cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/> [cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>

1 0

Visit of Dr. David Eidelberg
by networking＠manitobaneuroscience.ca 12 Mar '18

12 Mar '18

/Sent on behalf of Dr. Ji Hyun Ko Dear all, Dr. David Eidelberg is visiting Winnipeg and offering two seminars (one at Bannatyne campus and one at Fort Garry campus). Please see the attached posters. Best, Ji Hyun Ji Hyun Ko, PhD Assistant Professor Department of Human Anatomy and Cell Science Max Rady College of Medicine, Rady Faculty of Health Sciences University of Manitoba Principal Investigator Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Science Centre Mailing Address: SR452 - 710 William Avenue Winnipeg, MB R3E 0Z3 Canada Tel: +1-204-318-2566 Email: ji.ko(a)umanitoba.ca <mailto:ji.ko@umanitoba.ca> http://www.kolabneuro.com/ ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

1 0

Visit of Dr. David Eidelberg
by info＠manitobaneuroscience.ca 05 Mar '18

05 Mar '18

/Sent on behalf of Dr. Ji Hyun Ko Dear all, As part of Biomedical Engineering Seminar Series (4pm, Fort Garry campus), I invited Dr. David Eidelberg (March 15th, 2018). He will also give a talk in the Bannatyne campus at noon. David Eidelberg, MD is the Susan and Leonard Feinstein Professor of Neurology and Neuroscience, and has served as Director of the Center for Neurosciences at The Feinstein Institute for Medical Research since its founding in 2001. A neurologist and neuroscientist, he is widely regarded for his pioneering work on network dysfunction in brain disease. Under his direction, the Eidelberg group has developed innovative computational approaches using imaging to identify specific network biomarkers for a variety of brain disorders ranging from Parkinson's, Alzheimer's, and Huntington's disease to Dystonia, Tourette's syndrome and obsessive compulsive disorder. Disease-related networks are being assayed in individual patients to distinguish between clinically similar "look-a-like" conditions, monitor disease progression, and evaluate new treatments for these disorders. Dr. Eidelberg received his medical degree from Harvard Medical School. He completed his residency in neurology there, followed by postdoctoral training in brain imaging in London and New York. Dr. Eidelberg has authored over 250 peer-reviewed original articles, 100 reviews and editorials, and an edited volume (Imaging in Parkinson's Disease, Oxford University Press, 2011). He currently serves on the editorial boards of several major journals, and is editor-in-chief (with Professor Jean-Marc Leger) of Current Opinion in Neurology. He is a scientific advisor to the National Institutes of Health (NIH), U.S. Department of Defense, the Michael J. Fox Foundation, and the Collaborative Center for X-linked Dystonia Parkinsonism at Massachusetts General Hospital. Now, I am trying to develop an itinerary for his visit. Please email me (ji.ko(a)umanitoba.ca <mailto:ji.ko@umanitoba.ca> ) if any of you are interested in meeting with him in-person with your available time on March 15th. Best, Ji Hyun Ji Hyun Ko, PhD Assistant Professor Department of Human Anatomy and Cell Science Max Rady College of Medicine, Rady Faculty of Health Sciences University of Manitoba Principal Investigator Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Science Centre Mailing Address: SR452 - 710 William Avenue Winnipeg, MB R3E 0Z3 Canada Tel: +1-204-318-2566 Email: ji.ko(a)umanitoba.ca <mailto:ji.ko@umanitoba.ca> http://www.kolabneuro.com/ ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

1 0

Brain Awareness Week calendar - PDF
by outreach＠manitobaneuroscience.ca 05 Mar '18

05 Mar '18

cid:image001.jpg@01D158FE.B69B8D00 Hello again everyone, If anyone needs the Brain Awareness Week calendar in PDF format, here it is. All the best, Sari Sari S. Hannila, PhD Director of Outreach, Manitoba Neuroscience Network cid:image004.jpg@01D158FE.B69B8D00

1 0

Brain Awareness Week 2018
by outreach＠manitobaneuroscience.ca 05 Mar '18

05 Mar '18

cid:image001.jpg@01D158FE.B69B8D00 Hello everyone, I am pleased to unveil the MNN's full schedule of events for Brain Awareness Week 2018. Many of these events are for the general public, but please take note of the two special lectures that will be taking place next week. Dr. Karim Fouad from the University of Alberta will be speaking on Thursday, March 15th, and on Wednesday, March 14th, we will be hosting Canada Excellence Research Chair Dr. Pierre Marquet from Universite Laval. Dr. Marquet is a world leader in the fields of psychiatry and neurophotonics, and his work combines clinical studies with innovative imaging technologies to identify biomarkers for autism, depression, and bipolar disorder. I encourage you all to attend both lectures. Dr. Marquet will be available for meetings at the Bannatyne campus on Wednesday, March 14th. If you would like to meet with him, please send an email to Kae Normandeau kae.normandeau(a)umanitoba.ca by Wednesday, March 7th. Please feel free to share this events calendar with your students and lab members, and anyone else who may be interested. I hope you enjoy these events, and thank you for your support of the MNN and our outreach programs. Best wishes, Sari Sari S. Hannila, PhD Director of Outreach, Manitoba Neuroscience Network cid:image004.jpg@01D158FE.B69B8D00

1 0

BAW Special Lecture - Dr. Karim Fouad | Thurs. Mar 15 @12noon
by Manitoba Neuroscience Network 02 Mar '18

02 Mar '18

cid:image001.jpg@01D158FE.B69B8D00 SPECIAL LECTURE: B R A I N A W A R E N E S S W E E K D A T E Thursday, March 15th, 2018 12Noon *Followed by a Trainee Lunch in Rm 636 BMSB L O C A T I O N Rm 626 Basic Sci Bldg. S P E A K E R D R . K A R I M F O UA D C A N A D A R E S E A R C H C H A I R S P I N A L C O R D I N J U R Y T O P I C Promoting plasticity and recovery following spinal cord injury Karim Fouad studied Biology in Germany where he also performed his Graduate studies on motor control of invertebrates. During his time as PDF in Edmonton, with Dr. Pearson he switched to locomotor control in vertebrates, which triggered his interest in neuroplasticity. He expanded his research in the area of injury induced neuroplasticity in the groups of Drs. Schwab and Dietz in Zürich, Switzerland, especially in relation to spinal cord injuries. In 2001 he started his group in at the University of Alberta in Edmonton, where he is now a Professor and Canada Research Chair in the Department of Physical Therapy, in the Faculty of Rehabilitation Medicine. Karim Fouads research focuses on repair of the injured spinal cord. This includes combined treatment approaches to regenerate lost connections but also to rewire spared circuitry. He uses rehabilitative training to study, and enhance mechanisms of neuro plasticity, but also as a tool to promote functional recovery when plasticity is pharmacologically enhanced. Over the last years he developed a more compressive view on plasticity exploring a wide range of changes that occur after spinal injuries, ranging from spasticity, to blood flow and mental health. /sent on behalf of Dr. Eftekhar Eftekharpour Coordinator, Seminar & Visiting Speaker Series Manitoba Neuroscience Network E: Eftekhar.Eftekharpour(a)umanitoba.ca Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Email: kjorund(a)sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092 St. Boniface Hospital Albrechtsen Research Centre Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies. ****************************************** <http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710 <https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480

1 0

MNN Seminar - Dr. Mike Jackson | Friday Mar 9 @ 9am
by Manitoba Neuroscience Network 02 Mar '18

02 Mar '18

cid:image001.jpg@01D158FE.B69B8D00 S E M I N A R & V I S I T I N G S P E A K E R S E R I E S D A T E Friday, March 9th, 2018 9 am L O C A T I O N PX236/238 PsycHealth Building S P E A K E R Dr. Mike Jackson Program Coordinator - Small Animal and Materials Imaging Core Facility, University of Manitoba T O P I C Small Animal and Materials Imaging Core Facility O B J E CT I V E S The University of Manitoba Small Animal and Materials Imaging Core Facility (SAMICF), part of the Central Animal Core Imaging and Transgenic Facilities, brings capabilities for both structural/anatomical and functional imaging to Manitoba scientists. SAMICF provides access to the following instrumentation: * SkyScan 1176 high resolution micro-CT imaging system, * IVIS Spectrum bioluminescence/fluorescence imaging system * VisualSonics Vevo2100 high resolution ultrasound imaging system * Siemens P4 and R4 micro-PET imaging systems * MR Solutions 7T MRI-PET imaging system. This presentation will highlight the extensive imaging capabilities offered by SAMICF and outline how Manitoba researchers can access and utilize this state-of-the-art instrumentation. /sent on behalf of Dr. Eftekhar Eftekharpour Coordinator, Seminar & Visiting Speaker Series Manitoba Neuroscience Network E: Eftekhar.Eftekharpour(a)umanitoba.ca Kelly Jorundson Coordinator, Membership & Operations Manitoba Neuroscience Network Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092 St. Boniface Hospital Albrechtsen Research Centre Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies. ****************************************** <http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710 <https://www.facebook.com/manitobaneuroscience/?fref=ts> cid:image007.png@01D29326.7E26D480 <https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro> cid:image010.png@01D29326.7E26D480

1 0

Neurocraft opening reception - March 2nd
by outreach＠manitobaneuroscience.ca 23 Feb '18

23 Feb '18

cid:image001.jpg@01D158FE.B69B8D00 Hello everyone, A quick reminder that Neurocraft opens one week from today at the C2 Centre for Craft! Please feel free to forward this message to members of your lab and anyone else who may be interested. Details are also available on the C2 Centre website: c2centreforcraft.ca/2018/02/12/neurocraft/ You can also check out our Facebook event for the opening reception here: https://www.facebook.com/events/423918171395814/ Best wishes, Sari cid:image004.jpg@01D158FE.B69B8D00

1 0